Microbiome & Chronic Diseases

Evidence Based Medicine

Mon 25 September 2023 Sign in

Disease ⇒ Chronic lung disease {40000280}

Record Keys
Type:	Disease
Parent:	[ ]
Definition:	Chronic lung disease

Details
Initialisation date:	[ ]
Other Terms:	CLD

Meta Information
MedDra ID:	10061768
MedDra Level:	pt
ICD:	[ ]
Category:	[ ]
Zone:	[ ]
Mechanism:	[ ]

Notes:

[ ]

Shared Reference Notes

[1.1]
- #Butyrate acid administration as a means of restoration of GI-microbiota has reduced the degree of lung #Fibrosis in animal models

References Notes

[ ]

↥ Microbiota

‐ Corynebacterium propinquum Nasopharyngeal swab Human [1.2]
‐ Haemophilus influenzae Nasopharyngeal swab Human [1.2]
‐ Mitis group streptococci Nasopharyngeal swab Human [1.2]
‐ Moraxella catarrhalis Nasopharyngeal swab Human [1.2]
‐ Moraxella nonliquefaciens Nasopharyngeal swab Human [1.2]
‐ Staphylococcus aureus Nasopharyngeal swab Human [1.2]

↧ Microbiota

[ ]

Intervention by Microbiota

[ ]

↥ Metabolome

[ ]

↧ Metabolome

[ ]

Intervention by Metabolome

[ ]

Related Factor

[ ]

Subclass

[ ]

References

[ ]

Author: MetaBiom
Identifier: 40000280
URL: https://www.metabiom.org/disease/180/chronic-lung-disease
Keywords: Microbiome, Dysbiosis, Chronic

Common References

[1.1] The Role of the Microbiome in Connective-Tissue-Associated Interstitial Lung Disease and Pulmonary Vasculitis [2022] [biomedicines] [Journal] [80003359]
[1.2] The microbiota in bronchoalveolar lavage from young children with chronic lung disease includes taxa present in both the oropharynx and nasopharynx [2016] [Microbiome] [Journal] [80000527]